Roberto Rodriguez-Jimenez
Overview
Explore the profile of Roberto Rodriguez-Jimenez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
1579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sepulveda-Robles O, Flores-Lujano J, Nunez-Enriquez J, Jimenez-Hernandez E, Duarte-Rodriguez D, Martin-Trejo J, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075581
Background: The few epidemiologic studies of infection exposure in early life and acute leukemia (AL) risk in Latino children have yielded inconsistent results, suggesting a possible effect of ethnicity. Here,...
2.
Segura A, Prohens L, Julia L, Amoretti S, RIbero M, Pino-Camacho L, et al.
Eur Neuropsychopharmacol
. 2025 Feb;
94:4-15.
PMID: 39956014
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed...
3.
Scala M, Del Rocio Gonzalez Soltero M, Bellido Esteban A, Biscaia Fernandez J, Ferreiro V, Romero-Ferreiro V, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Feb;
137:111288.
PMID: 39923913
Backgrounds: Oropharyngeal microbiota may be implicated in the onset and progression of psychotic disorders. This scoping review aims to map the existing evidence concerning the composition, diversity, and metabolic pathways...
4.
Scala M, Tabone M, Paolini M, Saluena A, Iturra R, Ferreiro V, et al.
Eur Eat Disord Rev
. 2025 Jan;
PMID: 39887544
Objective: This systematic review explores the associations between qualitative/quantitative changes in gut microbiota and psychopathological symptoms or other clinical features in patients with eating disorders (EDs). Secondary outcomes include exploring...
5.
Romero-Ferreiro V, Garcia-Fernandez L, Romero C, De la Fuente M, Diaz-Del Cerro E, Scala M, et al.
J Psychiatr Res
. 2025 Jan;
182:413-420.
PMID: 39884134
Introduction: Recent research has identified gut microbiota dysbiosis as a potential contributing factor in schizophrenia, leading to growing interest in exploring probiotics as a complementary approach to traditional antipsychotic treatments....
6.
Romero-Ferreiro V, Garcia-Fernandez L, Biscaia J, Romero C, Ferreiro C, Gonzalez-Soltero R, et al.
Complement Ther Med
. 2025 Jan;
89:103126.
PMID: 39798817
Background: Inflammatory markers play a pivotal role in schizophrenia, as they provide insight into the neuroinflammatory processes occurring in the context of the disorder. Elevated levels of these markers, particularly...
7.
Fares-Otero N, Verdolini N, Melero H, Andres-Camazon P, Vilajosana E, Cavone V, et al.
Psychol Med
. 2024 Dec;
:1-14.
PMID: 39679545
Background: Both childhood adversity (CA) and first-episode psychosis (FEP) have been linked to alterations in cortical thickness (CT). The interactive effects between different types of CAs and FEP on CT...
8.
Garcia-Fernandez L, Romero-Ferreiro V, Padilla S, Wynn R, Perez-Galvez B, Alvarez-Mon M, et al.
Psychiatry Res
. 2024 Dec;
344():116308.
PMID: 39647260
This study aimed to examine the cognitive effects of tDCS and the subjective cognitive improvement perceived by patients with schizophrenia. A total of 173 outpatients diagnosed with schizophrenia were recruited...
9.
Scala M, Sanchez-Reolid D, Sanchez-Reolid R, Fernandez-Sotos P, Romero-Ferreiro V, Alvarez-Mon M, et al.
Int Clin Psychopharmacol
. 2024 Dec;
PMID: 39641922
Deficits in social cognition may impair emotional processing and facial emotional recognition (FER) in patients with bipolar disorder (BD) and schizophrenia. FER is generally explored using photographs or images of...
10.
Garcia-Fernandez L, Romero-Ferreiro V, Penuelas-Calvo I, Alvarez-Mon M, Scala M, Romero-Ferreiro C, et al.
Harv Rev Psychiatry
. 2024 Nov;
32(6):207-217.
PMID: 39514868
Background: Cariprazine (CAR), an antipsychotic with partial agonism at the D3 receptor and higher affinity than dopamine, has shown significant procognitive effects in preclinical animal studies. This study systematically reviews...